These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 17589295

  • 1. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ.
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous generation of multivirus-specific and regulatory T cells for adoptive immunotherapy.
    Lugthart G, Albon SJ, Ricciardelli I, Kester MG, Meij P, Lankester AC, Amrolia PJ.
    J Immunother; 2012 Jan; 35(1):42-53. PubMed ID: 22130159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
    Keever-Taylor CA, Margolis D, Konings S, Sandford GR, Nicolette CA, Lawendowski C, Burns WH.
    Biol Blood Marrow Transplant; 2001 Jan; 7(5):247-56. PubMed ID: 11400946
    [Abstract] [Full Text] [Related]

  • 6. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
    Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP, Keyvanfar K, Barrett AJ.
    J Immunother; 2006 Jan; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
    [Abstract] [Full Text] [Related]

  • 7. A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants.
    Lucas KG, Sun Q, Burton RL, Tilden A, Vaughan WP, Carabasi M, Salzman D, Ship A.
    Hum Gene Ther; 2000 Jul 01; 11(10):1453-63. PubMed ID: 10910142
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun 01; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
    Regn S, Raffegerst S, Chen X, Schendel D, Kolb HJ, Roskrow M.
    Bone Marrow Transplant; 2001 Jan 01; 27(1):53-64. PubMed ID: 11244438
    [Abstract] [Full Text] [Related]

  • 10. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.
    Hum Immunol; 2004 May 01; 65(5):514-22. PubMed ID: 15172452
    [Abstract] [Full Text] [Related]

  • 11. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
    Paine A, Oelke M, Tischer S, Heuft HG, Blasczyk R, Eiz-Vesper B.
    J Immunother; 2010 Jan 01; 33(1):60-72. PubMed ID: 19952955
    [Abstract] [Full Text] [Related]

  • 12. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 01; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 13. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P.
    Mol Ther; 2006 Feb 01; 13(2):280-8. PubMed ID: 16219490
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
    Zandvliet ML, van Liempt E, Jedema I, Kruithof S, Kester MG, Guchelaar HJ, Falkenburg JH, Meij P.
    J Immunother; 2011 Apr 01; 34(3):307-19. PubMed ID: 21389867
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous ex vivo expansion of cytomegalovirus and Epstein-Barr virus-specific cytotoxic T lymphocytes using B-lymphoblastoid cell lines expressing cytomegalovirus pp65.
    Sun Q, Pollok KE, Burton RL, Dai LJ, Britt W, Emanuel DJ, Lucas KG.
    Blood; 1999 Nov 01; 94(9):3242-50. PubMed ID: 10556213
    [Abstract] [Full Text] [Related]

  • 16. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
    Forsberg O, Carlsson B, Tötterman TH, Essand M.
    Br J Haematol; 2008 Apr 01; 141(2):188-99. PubMed ID: 18307565
    [Abstract] [Full Text] [Related]

  • 17. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C, Wang Z, Lacey SF, Lalimarmo MM, Krishnan A, Longmate J, Diamond DJ.
    Exp Hematol; 2006 Apr 01; 34(4):497-507. PubMed ID: 16569596
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S.
    J Clin Oncol; 2005 Dec 10; 23(35):8942-9. PubMed ID: 16204009
    [Abstract] [Full Text] [Related]

  • 20. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 10; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.